Valeant Pharmaceuticals

• Bausch Health announces $1.21 billion settlement over stock plunge

  Bausch Health Companies Inc. says it will pay more than $1 billion to settle a lawsuit over a stock plunge that hit investors about four years ago.

  Health

  Dec 16, 2019
  
• Jeff Sessions seeks resignations of 46 Obama-era U.S. attorneys

  U.S. Attorney General Jeff Sessions abruptly asked the remaining 46 chief federal prosecutors left over from the Obama administration to resign on Friday.

  Mar 10, 2017
  
• Advertisement
• Canadian company’s story shows why Trump might succeed in lowering drug prices

  Donald Trump's tough talk on drug prices may force the pharmaceutical industry to abandon questionable financial engineering practices.

  Money

  Feb 3, 2017
• Advertisement
• Canada’s highest-paid CEOs make 193 times the average wage: report

  Canada's top-paid 100 CEOs make an average of $9.5 million a year, according to a study by the Canadian Centre for Policy Alternatives.

  Canada

  Jan 3, 2017
• Valeant Pharmaceuticals shares surge 25 per cent

  Despite posting its biggest one-day share gain Tuesday, the new CEO of struggling drugmaker Valeant Pharmaceuticals says the company could eventually undergo a rebranding.

  Money

  Aug 9, 2016
• Valeant offers discounts for two drugs

  Valeant Pharmaceuticals says it is offering rebates on the price of two heart drugs that have come under scrutiny by the U.S. Congress.

  Money

  May 16, 2016
• US lawmakers blast Canadian pharma company Valeant for price-gouging tactics

  American lawmakers accused Canadian drugmaker Valeant Pharmaceuticals of gouging patients to reward Wall Street investors at a hearing Wednesday.

  Apr 27, 2016
• Lawyer ‘manufacturing’ Cold-FX case: drug maker

  The lawyer pushing for a class-action lawsuit over the alleged shortcomings of a popular cold and flu remedy is manufacturing a case with no real complainants, a court has heard.

  Canada

  Apr 6, 2016
• Advertisement
• Makers of Cold-FX in B.C. court to fight allegations it misled consumers

  The makers of Cold-fX are in court today fighting allegations they ignored their own research and misled consumers about the short-term effectiveness of the popular cold and flu remedy.

  Canada

  Apr 4, 2016
• Advertisement
• Valeant facing SEC probe as drugmaker’s miseries mount

  Valeant Pharmaceuticals is entangled in an SEC investigation to compound the drugmaker's headaches as it grapples with questions about its pricing practices, finances and CEO's health.

  Money

  Feb 29, 2016